Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
MS patients must have access to the best treatment options.
Cerebrospinal fluid ceramides from patients with multiple sclerosis impair neuronal bioenergetics.
Interactions of innate and adaptive immunity in brain development and function.
Multiple sclerosis: Regenerative therapies for MS-hope on the horizon.
Clinico-electrophysiological profile and predictors of functional outcome in Guillain-Barre syndrome (GBS).
Experimental allergic encephalomyelitis in the New World monkey Callithrix jacchus.
Exercising away the blues: can it help multiple sclerosis-related depression?
Isolated paroxysmal dysarthria caused by a single demyelinating midbrain lesion.
Immunology and Oxidative Stress in Multiple Sclerosis: Clinical and Basic Approach.
Anesthetic technique in a patient with multiple sclerosis scheduled for laparoscopic nephrectomy for a renal tumor: a case report.
Comparison of diabetes patients with "demyelinating" diabetic sensorimotor polyneuropathy to those diagnosed with CIDP.
The neurotrophic hepatocyte growth factor induces protolerogenic human dendritic cells.
Sera from patients with seropositive neuromyelitis optica spectral disorders caused the degeneration of rodent optic nerve.
Evaluation of Multi-Atlas Label Fusion for In Vivo MRI Orbital Segmentation.
MS Prevalence and Patients' Characteristics in the District of Braga, Portugal.
Erratum to: Anosmin-1 over-expression regulates oligodendrocyte precursor cell proliferation, migration and myelin sheath thickness.
Sleep Disorders Reduce Health-Related Quality of Life in Multiple Sclerosis (Nottingham Health Profile Data in Patients with Multiple Sclerosis).
Increased iron accumulation occurs in the earliest stages of demyelinating disease: an ultra-high field susceptibility mapping study in Clinically Isolated Syndrome.
Difficulties in Planning Among Patients with Multiple Sclerosis: A Relative Consequence of Deficits in Information Processing Speed.
CLIPPERS-like MRI findings in a patient with multiple sclerosis.
Clinical and biomarker assessment of demyelinating events suggesting multiple sclerosis.
MRI lesions: a surrogate for relapses in multiple sclerosis?
Immune phenotypes of microglia in human neurodegenerative disease: challenges to detecting microglial polarization in human brains.
Micro RNA-155 participates in re-activation of encephalitogenic T cells.
Pages
« first
‹ previous
…
573
574
575
576
577
578
579
580
581
…
next ›
last »